Anesth Analg 2000;91:1327-1332
© 2000 International Anesthesia Research Society
CARDIOVASCULAR ANESTHESIA
Xenon Administration During Early Reperfusion Reduces Infarct Size After Regional Ischemia in the Rabbit Heart In Vivo
Benedikt Preckel, MD, DEAA*,
Jost Müllenheim, MD*,
Andrej Moloschavij, MD ,
Volker Thämer, MD , and
Wolfgang Schlack, MD, DEAA*
Institut für
*Klinische Anaesthesiologie and
Institut für Herz- und Kreislauf-Physiologie, Heinrich-Heine-Universität Düsseldorf, Germany
Address correspondence and reprint request to Benedikt Preckel, MD, DEAA, Institut für Klinische Anaesthesiologie, Heinrich-Heine-Universität, Postfach 10 10 07, D-40001 Düsseldorf, Germany. Address e-mail to benedikt{at}herzkreis.uni-duesseldorf.de
The noble gas xenon can be used as an anesthetic gas with many of the properties of the ideal anesthetic. Other volatile anesthetics protect myocardial tissue against reperfusion injury. We investigated the effects of xenon on reperfusion injury after regional myocardial ischemia in the rabbit. Chloralose-anesthetized rabbits were instrumented for measurement of aortic pressure, left ventricular pressure, and cardiac output. Twenty-eight rabbits were subjected to 30 min of occlusion of a major coronary artery followed by 120 min of reperfusion. During the first 15 min of reperfusion, 14 rabbits inhaled 70% xenon/30% oxygen (Xenon), and 14 rabbits inhaled air containing 30% oxygen (Control). Infarct size was determined at the end of the reperfusion period by using triphenyltetrazolium chloride staining. Xenon reduced infarct size from 51% ± 3% of the area at risk in controls to 39% ± 5% (P < 0.05). Infarct size in relation to the area at risk size was smaller in the xenon-treated animals, indicated by a reduced slope of the regression line relating infarct size to the area at risk size (Control: 0.70 ± 0.08, r = 0.93; Xenon: 0.19 ± 0.09, r = 0.49, P < 0.001). In conclusion, inhaled xenon during early reperfusion reduced infarct size after regional ischemia in the rabbit heart in vivo.
Implications: Xenon might be a suitable volatile anesthetic in an ischemia-reperfusion situation.
This article has been cited by other articles:

|
 |

|
 |
 
J. Frassdorf, S. De Hert, and W. Schlack
Anaesthesia and myocardial ischaemia/reperfusion injury
Br. J. Anaesth.,
July 1, 2009;
103(1):
89 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Huhn, A. Heinen, N. C. Weber, R. P. Kerindongo, G. T. M. L. Oei, M. W. Hollmann, W. Schlack, and B. Preckel
Helium-Induced Early Preconditioning and Postconditioning Are Abolished in Obese Zucker Rats in Vivo
J. Pharmacol. Exp. Ther.,
May 1, 2009;
329(2):
600 - 607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Laitio, J. W. Langsjo, S. Aalto, K. K. Kaisti, E. Salmi, A. Maksimow, R. Aantaa, V. Oikonen, T. Viljanen, R. Parkkola, et al.
The Effects of Xenon Anesthesia on the Relationship Between Cerebral Glucose Metabolism and Blood Flow in Healthy Subjects: A Positron Emission Tomography Study
Anesth. Analg.,
February 1, 2009;
108(2):
593 - 600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Pagel
Remote Exposure to Xenon Produces Delayed Preconditioning Against Myocardial Infarction In Vivo: Additional Evidence That Noble Gases Are Not Biologically Inert
Anesth. Analg.,
December 1, 2008;
107(6):
1768 - 1771.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Weber, J. Frassdorf, C. Ratajczak, Y. Grueber, W. Schlack, M. W. Hollmann, and B. Preckel
Xenon Induces Late Cardiac Preconditioning In Vivo: A Role for Cyclooxygenase 2?
Anesth. Analg.,
December 1, 2008;
107(6):
1807 - 1813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-H. Baumert, M. Hein, K. E. Hecker, S. Satlow, P. Neef, and R. Rossaint
Xenon or propofol anaesthesia for patients at cardiovascular risk in non-cardiac surgery
Br. J. Anaesth.,
May 1, 2008;
100(5):
605 - 611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-H Baumert, M. Hein, C. Gerets, T. Baltus, K. E. Hecker, and R. Rossaint
The Effect of Xenon Anesthesia on the Size of Experimental Myocardial Infarction
Anesth. Analg.,
November 1, 2007;
105(5):
1200 - 1206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dingley and R. S. Mason
A Cryogenic Machine for Selective Recovery of Xenon from Breathing System Waste Gases
Anesth. Analg.,
November 1, 2007;
105(5):
1312 - 1318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Pagel, J. G. Krolikowski, Y. H. Shim, S. Venkatapuram, J. R. Kersten, D. Weihrauch, D. C. Warltier, and P. F. Pratt Jr
Noble Gases Without Anesthetic Properties Protect Myocardium Against Infarction by Activating Prosurvival Signaling Kinases and Inhibiting Mitochondrial Permeability Transition In Vivo
Anesth. Analg.,
September 1, 2007;
105(3):
562 - 569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hanss, B. Bein, P. Turowski, E. Cavus, M. Bauer, M. Andretzke, M. Steinfath, J. Scholz, and P. H. Tonner
The influence of xenon on regulation of the autonomic nervous system in patients at high risk of perioperative cardiac complications
Br. J. Anaesth.,
April 1, 2006;
96(4):
427 - 436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-H. Baumert, K. E. Hecker, M. Hein, S. M. Reyle-Hahn, N. A. Horn, and R. Rossaint
Haemodynamic effects of haemorrhage during xenon anaesthesia in pigs
Br. J. Anaesth.,
June 1, 2005;
94(6):
727 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. D Casey, J. Chandler, D. Gifford, and F. Falter
Microbubble production in an in vitro cardiopulmonary bypass circuit ventilated with Xenon
Perfusion,
May 1, 2005;
20(3):
145 - 150.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Sanders, D. Ma, and M. Maze
Xenon: elemental anaesthesia in clinical practice
Br. Med. Bull.,
February 22, 2005;
71(1):
115 - 135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. G. Hartlage, E. Berendes, H. Van Aken, M. Fobker, M. Theisen, and T. P. Weber
Xenon Improves Recovery from Myocardial Stunning in Chronically Instrumented Dogs
Anesth. Analg.,
September 1, 2004;
99(3):
655 - 664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Preckel and W. Schlack
Editorial III: Xenon--cardiovascularly inert?
Br. J. Anaesth.,
June 1, 2004;
92(6):
786 - 789.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Sanders, N. P. Franks, and M. Maze
Xenon: no stranger to anaesthesia
Br. J. Anaesth.,
November 1, 2003;
91(5):
709 - 717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Preckel, D. Ebel, J. Mullenheim, J. Fra{beta}dorf, V. Thamer, and W. Schlack
The Direct Myocardial Effects of Xenon in the Dog Heart In Vivo
Anesth. Analg.,
March 1, 2002;
94(3):
545 - 551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Preckel, W. Schlack, T. Heibel, and H. Rutten
Xenon produces minimal haemodynamic effects in rabbits with chronically compromised left ventricular function
Br. J. Anaesth.,
February 1, 2002;
88(2):
264 - 269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Obal, B. Preckel, H. Scharbatke, J. Mullenheim, F. Hoterkes, V. Thamer, and W. Schlack
One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo
Br. J. Anaesth.,
December 1, 2001;
87(6):
905 - 911.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|